nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis
|
Goldring, Steven R. |
|
2012 |
|
4 |
p. 249-258 |
artikel |
2 |
Analytical considerations for the biochemical assessment of vitamin D status
|
Couchman, Lewis |
|
2017 |
|
4 |
p. 97-104 |
artikel |
3 |
Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis
|
Tseng, Olivia L. |
|
2018 |
|
4 |
p. 71-90 |
artikel |
4 |
Assessment of synovitis to predict bone erosions in rheumatoid arthritis
|
Bugatti, Serena |
|
2012 |
|
4 |
p. 235-244 |
artikel |
5 |
Biologicals and bone loss
|
Krieckaert, Charlotte L.M. |
|
2012 |
|
4 |
p. 245-247 |
artikel |
6 |
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future
|
Liu, Chau-Ching |
|
2013 |
|
4 |
p. 210-233 |
artikel |
7 |
Bone density, balance and quality of life of postmenopausal women taking alendronate participating in different physical activity programs
|
Borba-Pinheiro, Cláudio Joaquim |
|
2010 |
|
4 |
p. 175-185 |
artikel |
8 |
Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis
|
Goldring, Mary B. |
|
2012 |
|
4 |
p. 269-285 |
artikel |
9 |
Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions
|
Ruza, Ieva |
|
2013 |
|
4 |
p. 182-198 |
artikel |
10 |
Clinical significance of bone changes in osteoarthritis
|
Neogi, Tuhina |
|
2012 |
|
4 |
p. 259-267 |
artikel |
11 |
Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs
|
Fabule, John |
|
2014 |
|
4 |
p. 111-130 |
artikel |
12 |
Foot osteoarthritis: latest evidence and developments
|
Roddy, Edward |
|
2018 |
|
4 |
p. 91-103 |
artikel |
13 |
Imaging in ankylosing spondylitis
|
Østergaard, Mikkel |
|
2012 |
|
4 |
p. 301-311 |
artikel |
14 |
Imaging in gout: A review of the recent developments
|
Chowalloor, Priya Varghese |
|
2014 |
|
4 |
p. 131-143 |
artikel |
15 |
Important issues at heart: cardiovascular risk management in rheumatoid arthritis
|
Roubille, Camille |
|
2013 |
|
4 |
p. 163-165 |
artikel |
16 |
Intravenous zoledronate for osteoporosis: less might be more
|
Grey, Andrew |
|
2016 |
|
4 |
p. 119-123 |
artikel |
17 |
Latest advances in connective tissue disorders
|
Rao, Vijay |
|
2013 |
|
4 |
p. 234-249 |
artikel |
18 |
Management of antiphospholipid syndrome
|
Del Papa, Nicoletta |
|
2010 |
|
4 |
p. 221-227 |
artikel |
19 |
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
|
van den Oever, Inge A.M. |
|
2013 |
|
4 |
p. 166-181 |
artikel |
20 |
Management of chronic pain in the rheumatic diseases with insights for the clinician
|
Fitzcharles, Mary-Ann |
|
2011 |
|
4 |
p. 179-190 |
artikel |
21 |
Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications
|
Karras, Spyridon N. |
|
2016 |
|
4 |
p. 124-135 |
artikel |
22 |
Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia
|
Palmer, Robert H. |
|
2010 |
|
4 |
p. 201-220 |
artikel |
23 |
Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence
|
Zerbini, Cristiano A. F. |
|
2013 |
|
4 |
p. 199-209 |
artikel |
24 |
‘Old drugs for new applications’: can orthopedic research benefit from this strategy?
|
Pan, Xiaohua |
|
2011 |
|
4 |
p. 201-205 |
artikel |
25 |
Osteoporosis in men: insights for the clinician
|
Adler, Robert A. |
|
2011 |
|
4 |
p. 191-200 |
artikel |
26 |
Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications
|
Espinoza, Francisco |
|
2016 |
|
4 |
p. 107-118 |
artikel |
27 |
Selected aspects of the current management of myositis
|
Lilleker, James |
|
2016 |
|
4 |
p. 136-144 |
artikel |
28 |
Sodium oxybate: a potential new pharmacological option for the treatment of fibromyalgia syndrome
|
Swick, Todd J. |
|
2011 |
|
4 |
p. 167-178 |
artikel |
29 |
The epidemiology of osteoporosis and fractures in ankylosing spondylitis
|
Sambrook, Philip N. |
|
2012 |
|
4 |
p. 287-292 |
artikel |
30 |
The evolving role of biomarkers for osteoarthritis
|
Ishijima, Muneaki |
|
2014 |
|
4 |
p. 144-153 |
artikel |
31 |
The FIBRO System: a rapid strategy for assessment and management of fibromyalgia syndrome
|
Boomershine, Chad S. |
|
2010 |
|
4 |
p. 187-200 |
artikel |
32 |
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials
|
Favalli, Ennio Giulio |
|
2012 |
|
4 |
p. 213-223 |
artikel |
33 |
The role of bone morphogenetic proteins in ankylosing spondylitis
|
Carter, Shea |
|
2012 |
|
4 |
p. 293-299 |
artikel |
34 |
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
|
Geusens, Piet |
|
2012 |
|
4 |
p. 225-233 |
artikel |
35 |
The role of vitamin D in maintaining bone health in older people
|
Hill, Thomas R. |
|
2017 |
|
4 |
p. 89-95 |
artikel |
36 |
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications
|
Sattui, Sebastian E. |
|
2016 |
|
4 |
p. 145-159 |
artikel |
37 |
Treatment strategies for osteoarthritis patients with pain and hypertension
|
Verdecchia, Paolo |
|
2010 |
|
4 |
p. 229-240 |
artikel |